3 results
Approved WMOCompleted
To demonstrate that treatment with drotrecogin alfa (activated) 24 mcg/kg/h administered as an intravenous infusion for 96 hours reduces 28 day all-cause mortality in adult patients with septic shock compared with placebo.
Approved WMOCompleted
To investigate whether it is possible to manipulate perfusion in type 3 fibroids with MR-HIFU.
Approved WMORecruiting
The aim of the present study is to conduct a randomised controlled trial (RCT) to assess the effectiveness of a guided and unguided web based transdiagnostic intervention in treating university and PhD students with depression and/or anxiety.